Treatment of anal intraepithelial neoplasia

Anal intraepithelial neoplasia is common among HIV-positive men and a potential precursor of anal cancer

In this prospective pilot study, researchers investigated the safety and efficacy of topical treatment with 5FU in this group of patients.

The study included 46 men with grade 1-3 anal intraepithelial neoplasia who were treated with 5FU twice weekly for 16 weeks. Patients were followed up after 6 months.

A total of 18 patients had a complete response, 8 had a partial response and 17 did not respond to treatment. After 6 months, 50% of complete responders experienced recurrence.

The authors conclude that a substantial proportion of HIV-positive men with anal intraepithelial neoplasia respond to treatment with topical 5FU.
Richel O, Wieland U, de Vries HJC et al. Br J Dermatol 2010; 163: 1301-7

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

More from MIMS

Drug shortages - live tracker

Drug shortages - live tracker

Check on the latest drug supply issues with MIMS' shortages...

Novel MS drug gains NICE approval

Novel MS drug gains NICE approval

New NICE guidance recommends ocrelizumab (Ocrevus)...

Emollients, Potential Skin Sensitisers as Ingredients

Emollients, Potential Skin Sensitisers as Ingredients

Potential sensitising agents in emollient preparations.

NICE recommends new triple therapy option for diabetes

NICE recommends new triple therapy option for diabetes

Ertugliflozin (Steglatro) can now be prescribed routinely...